| CPC A61K 39/25 (2013.01) [A61P 37/04 (2018.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/6018 (2013.01)] | 49 Claims |
|
1. An immunogenic composition, comprising a ribonucleic acid (RNA) of a varicella-zoster virus (VZV) encoding a variant of the wild-type VZV gE glycoprotein;
wherein the sequence of the wild-type VZV gE glycoprotein is SEQ ID NO: 3;
wherein the variant of the VZV gE glycoprotein is the variant selected from: YK-VZV-020, YK-VZV-030, YK-VZV-031, YK-VZV-009, YK-VZV-010, YK-VZV-011, YK-VZV-012, YK-VZV-013 and YK-VZV-014,
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||